Grassley calls on Congress and NIH leaders to identify conflicts of interest in taxpayer sponsored medical research
WASHINGTON — Senator Chuck Grassley is asking members of Congress who hold leadership positions on the appropriations committee to join his effort to hold the National Institutes of Health accountable for monitoring conflicts of interest in government sponsored medical research.
“There’s mounting evidence that the NIH hasn’t done due diligence in keeping track of industry payments to medical researchers,” Grassley said. “With the objectivity and integrity of research at stake, along with public trust in the system, there are plenty of reasons for Congress to step in to establish penalties for grantees who fail to report financial conflicts and to bring transparency to taxpayer funded medical research.”
Current federal law requires the NIH to monitor financial conflicts of interest by requiringthe institutions who receive grants who receive grants to collect and manage information on themoney that their researchers receive from drug and device makers and others in industry. Recentreports have revealed that this tracking is not happening in individual cases. In addition, theInspector General for the Department of Health and Human Services reported in January that theNIH does not adequately monitor its extramural grants for conflicts of interest. Extramuralresearch is research supported funds from the NIH for researchers and organizations outside theNIH through a grant, contract or cooperative agreement.
Grassley said that NIH leaders need to send a clear message that hiding conflicts ofinterest due to either sloppiness or sneakiness will not be tolerated. “The monetary value andprestige of NIH grants is significant enough that the possibility of losing a grant for notcomplying with reporting requirements ought to be a strong incentive to follow the rules,” hesaid. With almost $24 billion in NIH research grants awarded this year, Grassley said that hehopes lawmakers with primary responsibility for directing those funds will also step in and makethe rules meaningful and shed light on what’s happening.
Yesterday, the Senate Labor-HHS Appropriations Subcommittee approved a $154 billionspending bill for fiscal year 2009 for education and medical research. The largest increase, $1billion, would go to the National Institutes of Health.
Grassley has sponsored bipartisan legislation with Senator Herb Kohl that would requirepharmaceutical drug and medical device makers to publicly report payments of over $500 to anyphysician. He said the current laws governing NIH grants would bring greater transparency, aswell, if they are enforced. The Director of the NIH pledged to “significantly enhance theidentification and management of FOCIs (financial conflicts of interest)” in a June 20, 2008 letter to Grassley. The Director also said that NIH is considering gathering public comments to modify the regulations that govern NIH extramural grants.
The letter from NIH Director Elias Zerhouni, M.D. is posted with this news release a thttp://finance.senate.gov
Two stories from the New York Times regarding conflicts of interest in medical researchsponsored by the NIH are also posted at this location.
The text of letters sent today from Grassley to the chairmen and ranking members of theSenate and House appropriations subcommittee for NIH funding are also posted with this newsrelease at http://finance.senate.gov.
Next Article Previous Article
- Wyden, Brown Demand Assurances Investigative Requests Handled Fairly
- Wyden Statement on Treasury Response to Halkbank Investigation
- Wyden: We Can't Go Back to When Health Care Was for the Healthy and Wealthy
- Wyden Statement on Health Care Price Transparency Announcement
- Wyden Releases New Watchdog Report On Hospice Oversight